Partnership Driven Growth Encore is rapidly expanding through acquisitions, in-licensing and co-marketing, signaling openness to external collaborations that can broaden its product pipeline and geographic reach. Target BD actions include exploring asset licensing deals, co-development, or distributor partnerships to accelerate growth.

Dermatology Portfolio Focus With a focus on acne and atopic dermatitis, there is opportunity to pitch complementary therapies, novel topical formulations or dermatology devices that fit into Encore's current lineup and improve patient outcomes.

Lean Growth Capital As a small, privately held company with available funding, Encore may value scalable contract manufacturing, supply chain optimization, and regulatory support to speed time to market and support future acquisitions.

US Market Expansion Headquartered in Malvern, Encore's US footprint positions them for national distribution partnerships, private label manufacturing, or co-marketing deals with dermatology clinics, wholesalers and specialty distributors.

Competitive Positioning Opportunities In a market dominated by large players, Encore can differentiate through exclusive co-branded products or licensing opportunities that complement established dermatology portfolios, enabling faster market access and competitive differentiation.